You need a healthy risk appetite and a steady hand to hold through massive volatility but, once you learn how to invest in penny stocks, you can begin your journey to true financial freedom. If you haven’t invested in small-cap companies in the past, stop what you’re doing right now and read our guide to get started: The Art of Investing in Penny Stocks in 2021.
We keep our ear to the ground (and our eyes on the news) to learn about all the hottest opportunities in the market. If you want to be the first to know about fresh IPOs, new sectors, and the latest market trends, be sure to become a member of the Edge community using the form at the bottom of this page.
Now that you have a better idea of what you’re in for, here’s a list of our top 5 companies under $5:
Cardiol Therapeutics
(Canada: CRDL) (U.S.: CRTPF)
Cardiol Therapeutics Inc. is a clinical-stage biotechnology company focused on developing innovative therapies for inflammatory heart disease.
Cardiol utilizes cannabidiol (CBD) as the central component of its drug formulation and produces pharmaceutical-grade CBD in-house. This approach, which aligns with that of GW Pharma, has been making headlines recently, as global biopharma giant Jazz Pharmaceuticals fully acquired GW in a US$7.2 billion transaction. In fact, compared to GW’s process, Cardiol has a much more efficient extraction method, with a significantly lower cost.
Plus, they are partnered up with Shoppers Drug Mart to develop and sell their CBD formulation through Shoppers’ online cannabis & CBD platform, as a proven treatment for paediatric epilepsy.
- $2.50 on November 26th (when we first mentioned them to our audience)
- $3.42 on January 14th
- $4.38 on March 16th
- 75.2% gain since initial post
- $143.7M current market cap
…
Victory Square Technologies
(Canada: VST) (U.S.: VSQTF) (Europe: 6F6)
Victory Square Technologies builds, acquires, and invests in promising start-ups, then provides the senior leadership and resources needed to fast-track growth. With a successful record of public and private exits, Victory Square is specialized in rapid scaling and monetization.
Victory Square’s “sweet spot is the cutting-edge tech that is shaping the fourth industrial revolution” by finding and founding companies that utilize AI, virtual reality/augmented reality, and blockchain technology to disrupt sectors like finance, health, and gaming.
2021 brings a specific focus on digital health technology, as the world moves further into a tech-first way of living.
- $0.53 on December 18th (first mention)
- $0.64 on January 14th
- $0.83 on March 16th
- 56.6% gain since initial post
- $62.9M current market cap
…
Rritual Superfoods Inc.
(Canada: RSF)
Rritual Superfoods specializes in nutrient-packed elixirs that aim to benefit your mental and physical well-being. Utilizing the plethora of health benefits from functional mushrooms, Rritual has multiple product lines that focus on different aspects of mind and body health.
Rritual’s products are free of GMO, animal products, gluten and soy. You’d be hard-pressed to find someone whose dietary restrictions wouldn’t allow for their products. Not to mention these “super powders” are kept sugar- and caffeine-free, granting you the freedom to add it to coffee, or add a healthy sweetener at your own leisure. Versatility allows the customization of a superfood-empowered diet, which further promotes longevity and consistency; after all, you’re more likely to continue when you can enjoy something exactly the way you like it.
With CPG powerhouses like David Kerbel (CEO) on the team, it’s no surprise Rritual has been moving at a blistering pace, achieving organic certification in a mere 6 weeks; a fraction of time compared to the 6-9 months it usually takes. With a strong network boasting connections to Walmart, Costco, Walgreens, CVS, and Safeway… you can say Rritual is in very good hands.
- $0.30 IPO financing (first mention)
- $0.52 on March 9th (listing debut)
- $0.90 on March 16th
- 200% gain since IPO
- 55M current market cap
…
NeonMind Biosciences Inc.
(Canada: NEON) (U.S.: NMDBF) (Europe: 6UF)
NeonMind Biosciences Inc. is developing and commercializing products that contain legal medicinal mushrooms, whilst doing research and developing IP for various psychedelic compounds. Its first proposed drug candidate involves the administration of psilocybin (a complex organic compound found in psychedelic mushrooms) as a treatment for obesity and related illnesses for which NeonMind has started a preclinical trial at the University of British Columbia.
NeonMind has filed ten U.S. provisional patent applications, (two which have upgraded to PCT applications, which secure a globalized IP) claiming methods of aiding in weight loss, treating compulsive eating disorder, treating obesity or a complication of obesity, and/or altering the diet of an individual by administering psilocybin and/or other psychedelic compounds or their analogues or by administering psilocybin or its analogue in conjunction with therapy or other treatments.
NeonMind is also pursuing commercialization of its catalogue of proprietary medicinal mushroom product formulas. It recently launched a collection of four mushroom-infused coffees containing the medicinal mushrooms Lion’s Mane, Turkey Tail, Reishi and Cordyceps, among other nutraceuticals.
- $0.10 IPO financing (first mention)
- $0.21 on January 4th (listing debut)
- $$0.26 on March 16th
- 160% gain since initial post
- $32.5M current market cap
…
Cypress Development Corp.
(Canada: CYP) (U.S.: CYDVF) (Europe: C1Z1)
Cypress Development Corp. is an exploration company focused on developing a 100%-owned Clayton Valley Lithium Project in Nevada.
Simply put, it’s an EV play.
Electric vehicle batteries rely heavily on lithium (a resource with extremely limited supply) for production, and Cypress has an extremely attractive, producing claim in place. After the company told Tesla to beat it because his $3/share acquisition price was too low, it became clear that Cypress believes they have a long way to grow.
- $0.55 on November 12th (first mention)
- $1.32 on March 16th
- 140% gain since initial post
- $130.3M current market cap
[/fusion_text][fusion_text columns=”” column_min_width=”” column_spacing=”” rule_style=”default” rule_size=”” rule_color=”” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” class=”” id=”” animation_type=”” animation_direction=”left” animation_speed=”0.3″ animation_offset=””]
As you may know, we focus on small-cap companies within the market. We like innovation, we like disruption, we like scalability.
However, most of all, we like 10x opportunities.
We’re always keeping companies on our radar that have a winning mandate, solid management, and worthy fundamentals. We would like to share with you an updated collection of our top 5 companies under $5 that we think you should keep an eye on.
This collection is always rotating, as we’re keeping a close eye on what’s hot and what’s not.
Head over to the link in our bio to check out our current list.
Disclaimer: Cardiol Therapeutics, NeonMind Biosciences, Rritual Superfoods, and Victory Square Technologies are communications clients of Edge. We own shares in Cardiol Therapeutics, NeonMind Biosciences, Rritual Superfoods, Victory Square Technologies and Cypress Development Corp.
…
Stay Informed
We’re going to be updating this list on a rolling basis, removing those that go above $5 and adding in new opportunities. If you want to be the first one to know when we update this list, be sure to sign up to our mailing list here:
We are passionate investors and, if we could, we’d spend 100% of our time talking about new and growing companies. You’re here, so we know that you feel similarly. Our platforms are designed to inform, empower, and connect investors from all sides of the market to make money, together.
Follow us on Instagram and TikTok for hot information, delivered daily. Subscribe to our newsletter for weekly recaps of the most important things happening in finance.
Join our Discord to talk about the latest market trends, upcoming IPOs and share our collective knowledge.
We’re happy that you’re here. Now let’s go make some money!
This release is a commercial advertisement prepared by Edge Investments and is for general information purposes only. This is a Native Advertisement, meaning it is an informational paid marketing piece. Edge Investments, with the website www.edge.investments makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold, or held by viewers that learn of the profiled companies through our website. Please review all investment decisions with a licensed investment advisor. This Advertorial was paid for by some of the companies listed in this article in an effort to enhance public awareness of the companies and their securities. This Advertorial contains forward-looking statements that involve risks and uncertainties. This Advertorial contains or incorporates by reference forward-looking statements, including certain information with respect to plans and strategies of the featured Company. As such, any statements contained herein or incorporated herein by reference that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, the words believe(s) anticipate(s), plan(s), expect(s), project(s) will make told, and similar expressions are intended to identify forward-looking statements. There are a number of important factors that could cause actual events or actual results of the Company to differ materially from these indicated by such forward-looking statements. Certain statements contained herein constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934 and Canadian securities law. Further, this document includes statements regarding business, financing, business trends, future operating revenues and expenses and there can be no assurance that such expectations will prove to be correct. Investors are cautioned that any forward-looking statements made by the Company, or contained in this advertorial are not guarantees of future performance, and that the Issuers actual results may differ materially from those set forth in the forward-looking statements. Difference in results can be caused by various factors including, but not limited to, the Company’s ability to be able to successfully complete planned funding agreements, to successfully market its products in competitive industries or to effectively implement its business plan or strategies. To reiterate, information presented in this advertorial contains forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact and may be forward-looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward-looking statements in this advertorial may be identified through the use of words such as expects, will, anticipates, estimates, believes, may, or by statements indicating certain actions may, could, or might occur.